ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 517,68
1,22%
Dow Jones
40 589,34
1,64%
DAX
18 417,55
0,62%
Brent Oil
79,745
0,00%
Bitcoin
67 839,14
-0,11%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Merck and Co Inc (MRK)

  7. Merck and Co Inc (MRK) Actualités

MRK Merck and Co Inc

125,26
-0,59 (-0,47%)
27 Juil 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Merck and Co Inc MRK NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,59 -0,47% 125,26 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
126,84 125,05 128,73 125,26 125,85
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/7/202412:50BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
23/7/202418:52BWMerck Announces Fourth-Quarter 2024 Dividend
23/7/202412:45BWMerck Announces Topline Results from Phase 2b/3 Trial of..
16/7/202412:45BWMerck to Share New Research and Host Community-Focused..
12/7/202412:45BWMerck Completes Acquisition of EyeBio
09/7/202414:30BWMerck Animal Health Completes Acquisition of Elanco’s Aqua..
09/7/202414:28PRNUSElanco Completes Sale of Aqua Business
01/7/202414:15BWMerck and Orion Announce Mutual Exercise of Option Providing..
01/7/202412:45BWMerck to Hold Second-Quarter 2024 Sales and Earnings..
28/6/202412:53BWMerck Receives Positive EU CHMP Opinion for WINREVAIR™..
28/6/202402:18BWCDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™..
27/6/202413:13IHMARKETNEWSInteractive Brokers Loses $48 Million on NYSE, Amazon..
27/6/202401:45BWPatritumab Deruxtecan BLA Submission Receives Complete..
25/6/202422:05BWUSDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu..
18/6/202413:02IHMARKETNEWSFisker Files for Bankruptcy, Chegg Stocks Rise on 23%..
17/6/202423:29BWU.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent..
17/6/202423:15BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus..
05/6/202412:45BWMerck to Participate in the Goldman Sachs 45th Annual Global..
04/6/202421:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202420:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202415:10IHMARKETNEWSEconomic Worries May Lead To Weakness On Wall Street
30/5/202422:39EDGAR2Form CERT - Certification by an exchange approving..
30/5/202422:28EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
30/5/202422:14EDGAR2Form 8-K - Current report
29/5/202415:10IHMARKETNEWSRising Treasury Yields May Weigh On Wall Street
29/5/202413:34IHMARKETNEWSRobinhood Shares Surge 3.3% on Stock Buyback Announcement;..
29/5/202413:15BWFDA Grants Priority Review to Merck’s Application for..
29/5/202412:45BWMerck to Acquire EyeBio
28/5/202422:44IHMARKETNEWSNasdaq Climbs To Another Record Closing High But Dow Sees..
28/5/202422:31EDGAR2Form SD - Specialized disclosure report
28/5/202421:12BWMerck Announces Third-Quarter 2024 Dividend
28/5/202412:45BWMerck Announces Phase 3 KEYNOTE-522 Trial Met its Overall..
20/5/202412:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/5/202422:15EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
15/5/202417:31EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
15/5/202412:45BWMerck to Present New Data at 2024 ASCO Annual Meeting..
13/5/202412:45BWMerck Provides Update on Phase 3 KeyVibe-010 Trial..
09/5/202413:05PRNCASanté Canada approuve KEYTRUDA® pour le traitement, en..
09/5/202412:45BWMerck Provides Update on Phase 3 KEYNOTE-B21 Trial..
08/5/202412:45BWMerck to Participate in the Bank of America Securities 2024..
06/5/202422:29EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés